Showing 34,862 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Drug policy & policing

FDA Exempts Harm Reduction From Biggest Naloxone Access Restrictions

Editor's pick
Filter
27 September 2022
Men who have sex with men (MSM)

Gay Muslim men living with HIV in Senegal are being persecuted and report shame, violence and isolation

News
27 September 2022
Global health initiatives

Reimagining PEPFAR at 20 to End the HIV/AIDS Pandemic by 2030

Editor's pick
US Department of State
26 September 2022
Harm reduction

‘This program’s really saved us’: As Canada offers safer opioids to curb overdoses, will U.S. follow?

Editor's pick
STAT
26 September 2022
Injectable & long-acting HIV treatment

Compassionate Use of Long-Acting Cabotegravir Plus Rilpivirine in HIV

Editor's pick
Infectious Disease Advisor
26 September 2022
Cardiovascular disease

HIV and HCV Coinfection Raises Heart Attack Risk as People Age

Editor's pick
POZ
26 September 2022
Discrimination & the law

South Korea: Refusal of surgery for HIV patient discriminatory

Editor's pick
The Korea Herald
26 September 2022
HIV testing programmes & uptake

Programs Designed to Promote HIV Testing May Worsen Misinformation, Stigma

Editor's pick
Infectious Disease Advisor
26 September 2022
Coronavirus

The Haunting of (Long) COVID: Why the Pandemic Isn’t Over, and How It Affects PLWH

Editor's pick
TheBodyPro
26 September 2022
People who inject drugs

HIV spike among B.C. drug users associated with COVID-19-related service closures, research says

Editor's pick
CBC
26 September 2022
Mpox (monkeypox)

Second vaccine doses to be offered to those at highest risk from monkeypox

Editor's pick
UK Health Security Agency
26 September 2022
Climate change

Food insecurity among women in sub-Saharan Africa doubles the risk of HIV acquisition

News
26 September 2022
HIV prevention policy

To Meet Global HIV Prevention Goals, Expand The PEPFAR-FDA Tentative Approval Pathway

Editor's pick
Health Affairs
25 September 2022
Sexual health

What do healthcare workers really think of mHealth?

Editor's pick
Be In The Know
23 September 2022
New & experimental HIV treatments

Merck restarts islatravir HIV treatment studies, but abandons monthly PrEP

News
23 September 2022
TB treatment

South Africa to expedite TB diagnosis/treatment as cases continue to soar

Editor's pick
Medical Brief
22 September 2022
Mpox (monkeypox)

England's Health Secretary must prioritise monkeypox's devastating impact on sexual health services

Editor's pick
Terrence Higgins Trust
22 September 2022
Climate change

When Drought and HIV Collide

Editor's pick
Yarrow Global
22 September 2022
Finance & funding

Global Fund Partners Pledge Record Level of Support to End Deadly Diseases, Prevent Future Pandemics

Editor's pick
The Global Fund
22 September 2022
Finance & funding

Global Fund Still Short of $18 Billion Target – But UK and Italy Have Yet to Announce Pledges

Editor's pick
Health Policy Watch
22 September 2022
Harm reduction

After 21 years, Sydney’s supervised injecting centre model is hard to improve

Editor's pick
Cosmos
22 September 2022
Opportunistic infections

Varicella Zoster Virus Linked to High Morbidity, Health Care Costs in Patients With HIV

Editor's pick
Infectious Disease Advisor
21 September 2022
The search for a cure

License to Kill: Latency HIV-CRISPR pinpoints how to blow latent HIV’s cover

Editor's pick
Fred Hutch
21 September 2022
People who inject drugs

Success in containing and treating HIV among people injecting drugs in the UK has stalled in recent years

News
21 September 2022